Living well during and after treatment
The supportive-care tools with real evidence: exercise, heart protection, hair preservation, fitness assessment for older adults, and the questions to ask.
- 1FrontSupportive Care & Survivorship
Supportive care and survivorship covers everything that keeps a patient well enough to receive treatment, and well afterwards.
Why here The front that gets the least attention and changes daily life the most.
- 2TechnologyEstablishedExercise & lifestyle oncology
Structured exercise during and after treatment, which the CHALLENGE trial showed improves survival in colon cancer.
Why here Structured exercise improved survival in a randomised trial.
- 3IdeaStructured exercise prescribed like a drug in all curative-intent cancer care
The CHALLENGE trial showed a supervised exercise programme improves survival in colon cancer. Extend it to breast, prostate, and lung cancer with the same rigour.
Why here Why exercise should be prescribed like a drug.
- 4TechnologyEstablishedCardio-oncology
Protecting the heart from cancer treatments, which is increasingly important as patients live longer.
Why here Protecting the heart from anthracyclines, HER2 drugs, and immunotherapy.
- 5TechnologyEstablishedScalp cooling
A cold cap worn during chemotherapy that reduces hair loss by narrowing blood vessels in the scalp.
Why here Keeping hair through taxane chemotherapy.
- 6TechnologyEstablishedGeriatric assessment
Geriatric assessment is a structured check of an older patient's fitness, memory, and support that predicts treatment tolerance better than age.
Why here For older patients: fewer severe side effects without losing effect.
- 7TermImmune-related adverse events (irAEs)
Immune-related adverse events (irAEs) are the autoimmune side effects of checkpoint inhibitors: colitis, thyroid problems, rash, hepatitis, pneumonitis.
Why here Immunotherapy side effects to recognise early.
- 8TermInterstitial lung disease (ILD) / pneumonitis
Interstitial lung disease (ILD) is lung inflammation, a serious side effect of some ADCs (especially Enhertu) and immunotherapy.
Why here The lung side effect of some ADCs, and why prompt reporting matters.
- 9TechnologyEstablishedMRD / molecular residual disease testing
An ultra-sensitive blood test after surgery that detects leftover cancer months before a scan would.
Why here Blood tests during follow-up and what they can and cannot yet tell you.
- 10CompanyCancer Commons
Nonprofit that helps advanced-cancer patients navigate precision-oncology options and trials, free of charge.
Why here Free navigation help when options run thin.